Apr 10, 2001
Guidant Pre-Announces All-Time Record Quarterly Sales and Earnings

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced revenue of $671 million and adjusted earnings of $126.9 million for the first quarter of 2001.

The adjusted earnings met Wall Street's consensus estimate of $0.41 per share and is consistent with the company's guidance.

The reported earnings exclude a one-time charge associated with the ANCURE® System voluntary recall as previously announced. This charge will be less than previously estimated.

Further performance detail will be announced during the conference call and webcast on April 23, 2001.

The Company advised that it is issuing this release to offset possible misleading speculation in this time of stock market volatility.

A global leader in the medical technology industry, Guidant Corporation provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease.